Welcome to the era of precision medicine, where cancer genetics guide tailored treatments, eliminating the need for trial and error, empowering physicians and patients with effective and personalized treatment options
Cancer Treatment
Revolutionizing cancer treatment through advanced, cutting-edge technologies
At Oncode, we deliver personalized solutions that best suit your needs, because we care.
Planning & Patient Management
Unlock Precision with Clarity: Oncode's Comprehensive, Color-Guided Reports Streamline Treatment Design.
Welcome to the era of precision medicine, where cancer genetics guide tailored treatments, eliminating the need for trial and error, empowering physicians and patients with effective and personalized treatment options
Cancer Treatment
Revolutionizing cancer treatment through advanced, cutting-edge technologies
At Oncode, we deliver personalized solutions that best suit your needs, because we care.
Planning & Patient
Management
Unlock Precision with Clarity: Oncode's Comprehensive, Color-Guided Reports Streamline Treatment Design.
Tailor-made solutions best suited for your needs
SOLID TUMOURS
BLOOD CANCERS
TISSUE BIOPSY
(FFPE BLOCK/SLIDES)
Comprehensive tissue biopsy testing solutions encompassing an extensive range of genetic analyses, including SNVs, InDels, CNV, fusions/rearrangements, SNPs, MSI and HRD, by utilizing technology including NGS, PCR, fragment analysis, MLPA, and more.
LIQUID BIOPSY
(BLOOD)
Liquid biopsies offer a broad range of clinical applications throughout the treatment cycle, providing comprehensive genetic analyses that overcome limitations and unavailability associated with tissue biopsies, while offering insights into tumor heterogeneity.
A spectrum of assays, ranging from single gene PCR to Next Generation Sequencing (NGS) panels, is available for detecting mutations and fusions in:
Tailor-made solutions best suited for your needs
SOLID TUMOURS
BLOOD CANCERS
Myeloproliferative Neoplasms (MPN)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in MPN.
ACUTE MYELOID LEUKEMIA (AML)
From single gene PCR assays to panels of Next Generation Sequencing (NGS) assays are available for the detection of mutation(s) & fusion(s) in AML.
Acute Lymphoblastic Leukemia (ALL)
PCR and Next Generation Sequencing assays for the detection of fusion(s) in ALL.
Non-Hodgkin’s Lymphoma (NHL)
Assays including BRAF and/ or MYD88 PCR panels for the detection of mutation(s) in NHL.
Endorsed by Healthcare Professionals, Adored by Patients and Trusted by Partners